Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 24

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 24
---
 February 25, 2025

    Shweta Singh Maniar

    /s/ MICHAEL PAOLUCCI
     
    Director
     
    February 25, 2025

    Michael Paolucci

83

ORTHOFIX MEDICAL INC. 

Statement of Management’s Responsibility for Financial Statements 

To the Shareholders of Orthofix Medical Inc.: 

Management is responsible for the preparation of the consolidated financial statements and related information that are presented in this Annual Report. The consolidated financial statements, which include amounts based on management’s estimates and judgments, have been prepared in conformity with accounting principles generally accepted in the United States. Other financial information in the report to shareholders is consistent with that in the consolidated financial statements. 

The Company maintains accounting and internal control systems to provide reasonable assurance at a reasonable cost that assets are safeguarded against loss from unauthorized use or disposition, and that the financial records are reliable for preparing financial statements and maintaining accountability for assets. These systems are augmented by written policies, an organizational structure providing division of responsibilities, and careful selection and training of qualified personnel. 

The Company engaged Ernst & Young LLP, independent registered public accountants, to audit and render an opinion on the consolidated financial statements in accordance with auditing standards of the Public Company Accounting Oversight Board (United States). These standards include an assessment of the systems of internal controls and tests of transactions to the extent considered necessary by them to support their opinion. 

The Board of Directors, through its Audit and Finance Committee, consisting solely of outside directors of the Company, meets periodically with management and our independent registered public accountants to ensure that each is meeting its responsibilities and to discuss matters concerning internal controls and financial reporting. Ernst & Young LLP has full and free access to the Audit and Finance Committee. 

Wayne Burris 

Chairman of the Audit and Finance Committee 

Massimo Calafiore

President and Chief Executive Officer, Director 

Julie Andrews

Chief Financial Officer 

84

ORTHOFIX MEDICAL INC. 

Index to Consolidated Financial Statements

    Page

    Index to Consolidated Financial Statements
     
    F-1

    Report of Independent Registered Public Accounting Firm (PCAOB ID: 42)
     
    F-2

    Consolidated Balance Sheets as of December 31, 2024 and 2023
     
    F-4

    Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024, 2023, and 2022
     
    F-5